China Diabetes Market 2018 by Type, Application, End-User, Share and Geography - Outlook 2023

1. China Diabetes Market Propelled by Improving Access to Treatment Copyright © IMARC. All Rights Reserved

2. About IMARC Group Report Description IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description China Diabetes Market Propelled by Improving Access to Treatment Over the past few years, the China diabetes market has witnessed a positive growth on account of a number of positive forces which include augmenting demand for better healthcare products and services, ageing population and unhealthy lifestyle. According to the latest report by IMARC Group, titled “China Diabetes Market Report: 2018-2023”, the China diabetes market reached a value of more than US$ 3 Billion in 2017, exhibiting a CAGR of more than 15% during 2010-2017. Diabetes, also known as diabetes mellitus, is a long-term health condition which leads to an increase in the levels of blood sugar. During this chronic disease, the patient’s body does not produce enough insulin to break down the sugar available in food products. Currently, China has one of the largest diabetic population in the world with around 10% of the adult population living with the disease owing to unhealthy changes in lifestyles such as high level of smoking and alcohol consumption, particularly among the rural and middle-class population. Apart from this, the prevalence of diabetes is higher at a relatively young age and lower BMI level in China as compared to the western population.

4. Report Description and Highlights Report Description Market Trends: The healthcare reforms undertaken by the Chinese government represent the major factor which has driven the market growth. Earlier, the healthcare system in the region operated under a rudimentary socialist system with little to no access to modern healthcare services. However, the government has encouraged foreign investments in recent years, allowing multinational companies to offer their services in the region. This has improved the access to treatment, enabling the patients to identify diabetes at earlier stages and manage it. Additionally, as people over the age of 65 years are at a higher risk of diabetes when compared to the younger generations, the aging population has further led to a growth in the demand for diabetes management products. Moreover, rising disposable incomes coupled with rapid urbanization have led to a rise in the consumption of junk food, lack of safe spaces to exercise, sedentary lifestyles, etc., further increasing the risk of diabetes. However, the geographical disparity in China, in terms of healthcare services provided to the eastern and western provinces and the rural and urban regions, hinders the growth of the China diabetes market. Looking forward, the market is projected to reach a value of nearly US$ 6 Billion by 2023. Read more here: http://bit.ly/2DElcav

5. Report Description and Highlights Report Description Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=556&flag=B

6. Report Description and Highlights • Market Summary: • The diabetes market in China has been categorized into two main segments, namely, insulin and oral antidiabetics. Currently, the insulin segment holds the majority of the market share on account of a rise in the number of facilities established across the nation which produce and supply insulin pumps along with other insulin delivery systems. • The competitive landscape of the market has also been examined with some of the key players being Sinocare, Roche, Abbott, Johnson & Johnson, Bayer, and Beckman Coulter. • Browse More Related Reports:  • Japan Diabetes Market: http://bit.ly/2TqGlKu • France Diabetes Market: http://bit.ly/2PHF0Rl

7. Report Description and Highlights Report Description © 2017 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

8. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com